Register to attend. Volunteer to help. Register as a health fair vendor. Myasthenia Gravis Foundation of America thanks its national sponsors.
Monthly Archives: July 2023
From our partner, argenx is a new podcast, the “Untold Stories: Life with Myasthenia Gravis.” Take a listen to the first season that explores the real and untold stories of life with myasthenia gravis (MG), finding hope and community in each MG journey.
Argenx Announces U.S. FDA Approval of Vyvgart Hytrulo Injection for Subcutaneous Use in Generalized MG What you need to know: Argenx announced FDA approval for Vyvgart Hytrulo (efgartigimod alfa and hyaluronidase-qvfc), a subcutaneous injection for adult gMG patients who are anti-acetylcholine receptor (AChR) antibody positive. Delivered via injection instead of through an IV infusion, the… Read more »
UCB Announces U.S. FDA Approval of RYSTIGGO[®] (rozanolixizumab-noli) for the Treatment of Adults with Generalized Myasthenia Gravis What you need to know: This is a new therapy that is designed as a monoclonal antibody that binds to the neonatal Fc receptor (FcRN). The delivery of this therapy is subcutaneous injection – so it’s quicker and… Read more »